F-1/A: Steakholder Foods Amends F-1 Filing, Details Recent Capital Raises and Corporate Governance

Steakholder Foods Ltd. has filed an amendment to its F-1 registration statement, primarily to include new exhibits related to recent and ongoing capital raising activities and to clarify corporate governance provisions regarding officer and director indemnification.

Summary

• The F-1/A amendment was filed to include Exhibits 4.4 (Form of Common Warrant), 4.5 (Form of Pre-Funded Warrant), 4.6 (Form of Placement Agent Warrant), and 10.18 (Form of Securities Purchase Agreement).
• The prospectus (Part I) of the original registration statement remains unchanged.
• The company's articles of association permit exculpation and indemnification of office holders to the fullest extent allowed by Israeli Companies Law and Israeli Securities Law.
• Indemnification for officers and directors is limited to foreseeable events, with a maximum aggregate amount of the higher of $5 million or 25% of shareholders' equity.
• The SEC's opinion states that indemnification of directors and office holders for liabilities under the Securities Act of 1933 is against public policy and therefore unenforceable.
• In July 2023, the company issued warrants to purchase 120,000 ADSs at $55.00 per ADS and placement agent warrants for 8,400 ADSs at $62.50 per ADS.
• On February 27, 2025, the company entered into a Securities Purchase Agreement (SPA) with Alumni, selling 38,532 ADSs at $5.6955 per ADS, along with warrants to purchase up to 219,472 ADSs and February Pre-Funded Warrants.
• Also on February 27, 2025, an $8 million equity line of credit (ELOC) was established with Alumni, for which the company paid a Commitment Fee of 39,934 Commitment Shares.
• On June 5, 2025, the company executed a private placement agreement for 124,286 ADSs at $7.00 per ADS.
• Concurrently on June 5, 2025, a convertible loan of $870,000 was secured, convertible into ADSs at $7.00 per ADS upon the acquisition of Twine.
• The company undertakes to file post-effective amendments for prospectus updates, fundamental changes, and material distribution plan information, and to include required financial statements for delayed or continuous offerings.
• The company will reserve sufficient ADSs and Ordinary Shares for issuance under the agreements and warrants, and will maintain listing on its primary Trading Market, applying to list all newly issued securities.

Sentiment

Score: 7

Explanation: The document is a regulatory amendment, which is generally neutral. However, the detailed disclosure of multiple recent and ongoing capital raises, including an $8 million equity line of credit, indicates successful efforts to secure funding, which is a positive for a growth-stage company. The corporate governance details are standard compliance, with the SEC's opinion on indemnification being a common disclosure rather than a specific negative for the company's operations.

Positives

• The company has successfully secured multiple capital raises, including a private placement, an equity line of credit, and a convertible loan, indicating continued access to funding.
• The establishment of an $8 million equity line of credit provides a flexible funding mechanism for future operations.
• The company maintains directors and officers liability insurance and has indemnification and exculpation agreements in place for its office holders, providing a level of protection for management.

Negatives

• The SEC's opinion that indemnification for liabilities arising under the Securities Act of 1933 is against public policy and unenforceable could expose directors and officers to greater personal liability for certain claims.
• The company's ability to indemnify officers and directors is subject to specific limitations under Israeli law, including prohibitions on exculpation for breaches of duty of loyalty or intentional/reckless duty of care.

Risks

• Indemnification of directors and officers for liabilities under the Securities Act of 1933 is considered against public policy by the SEC and is unenforceable, potentially increasing personal risk for these individuals.
• The company's ability to exculpate office holders from liability for breaches of duty of loyalty is prohibited under Israeli Companies Law.
• The company is prohibited from indemnifying, exculpating, or insuring office holders for acts committed with intent to derive illegal personal benefit, or for fines, monetary sanctions, or forfeits.
• Failure to timely deliver Warrant ADSs upon exercise could result in liquidated damages payable to the holder, at a rate of $10 per Trading Day (increasing to $20 after the third day) for each $1,000 of Warrant ADSs subject to exercise.
• The company is subject to restrictions on subsequent equity sales for 60 days post-closing, with a prohibition on Variable Rate Transactions for one year, which could limit financing flexibility.

Future Outlook

The company intends to offer securities on a delayed or continuous basis after the registration statement becomes effective. It also plans to acquire the entire outstanding share capital of Twine, which would trigger the conversion of a recent $870,000 loan into ADSs.

Industry Context

Steakholder Foods Ltd. operates in the innovative food technology sector, specifically focusing on cultivated meat products. This regulatory filing, while not directly addressing operational advancements, is crucial for the company's financial stability and ability to raise capital, which is vital for research, development, and scaling in a capital-intensive emerging industry.

Comparison to Industry Standards

• The indemnification and exculpation provisions for directors and officers are structured under Israeli Companies Law, which has specific requirements and limitations, such as the inability to exculpate for breaches of duty of loyalty, differing from some U.S. state corporate laws that may allow broader exculpation.
• The SEC's stance on the unenforceability of indemnification for Securities Act liabilities is a standard regulatory position for U.S.-listed foreign private issuers, aligning with general U.S. public policy on investor protection.
• The capital raising activities, including private placements and an equity line of credit, are common financing strategies for growth-stage companies in emerging industries like cultivated meat, which typically require significant investment before commercialization.

Corporate Governance

Legal Proceedings

• No action, suit, inquiry, notice of violation, proceeding or investigation pending or threatened against or affecting the company or any subsidiary that could result in a Material Adverse Effect.
• No investigation by the Commission involving the company or any current or former director or officer is pending or contemplated.
• The Commission has not issued any stop order or other order suspending the effectiveness of any registration statement filed by the company or any subsidiary.
• No Action or Proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company or any Subsidiary with respect to Money Laundering Laws is pending or threatened.

Related Party Transactions

• No officers, directors, or employees are party to any transaction with the company or any subsidiary in excess of $120,000, other than for salary, consulting fees, expense reimbursement, and other employee benefits, except as disclosed on Schedule 3.1(r).

Stakeholder Impact

• Shareholders: The various capital raises could lead to dilution, but also provide necessary funding for company operations and growth. The indemnification policies affect the protection afforded to directors and officers, which can indirectly impact shareholder confidence.
• Employees: The company's share option plans and employee benefits are mentioned, indicating ongoing compensation structures. No material labor disputes are reported.
• Customers/Suppliers: No direct impact mentioned, but the company's financial stability from capital raises supports continued operations and potential product development.
• Creditors: The details of recent capital raises and the equity line of credit provide insight into the company's liquidity and ability to meet its financial obligations.

Next Steps

• The company will file further amendments to the registration statement to declare its effectiveness or await SEC determination.
• The company will continue to file all required reports under the Exchange Act.
• The company will apply to list all newly issued Shares, Warrant Shares, and Warrant ADSs on its Trading Market.
• The company plans to consummate the acquisition of Twine, which will trigger the conversion of the $870,000 convertible loan.

Key Dates

Keywords

Steakholder Foods, SEC filing, F-1/A, registration statement, warrants, ADSs, equity line of credit, private placement, convertible loan, corporate governance, indemnification, exculpation, capital raise, securities offering, Israeli Companies Law, Securities Act of 1933, food technology, alternative protein